huberman glp-1 The Science of Hunger & Medications to Combat Obesity Neuroscientist Andrew Huberman believes GLP-1s

GLP-1 medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, are approved by the FDA for their specific indications after rigorous testing and clinical trials

When blood sugar levels drop quickly, it can lead to changes in blood flow that may predispose certain individuals to ischemic damage in the optic nerve

Medication tapering and transition Once members hit their goals, coaches and clinicians guide them through a structured tapering plan

Having a provider who can assess your response, adjust your dose at the right time, and catch early issues makes the difference between grinding through plateaus and moving past them

Effect of different types of regular exercise on physical fitness in adults with overweight or obesity: Systematic review and meta-analyses

Our multidisciplinary team includes bariatric surgeons, medical weight loss physicians, advanced practice nurses, registered dietitians and health psychologists